NASDAQ:PETQ - PetIQ Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $39.95 -1.82 (-4.36 %) (As of 09/20/2018 09:07 AM ET)Previous Close$41.77Today's Range$39.08 - $42.7552-Week Range$17.03 - $43.93Volume573,400 shsAverage Volume697,183 shsMarket Capitalization$1.07 billionP/E Ratio102.44Dividend YieldN/ABeta0.37 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PetIQ, Inc. develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through distributors as well as through retail stores, including approximately 40,000 retail pharmacy locations. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. Receive PETQ News and Ratings via Email Sign-up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Drugs, proprietaries, & sundries Sub-IndustryN/A SectorMedical SymbolNASDAQ:PETQ CUSIPN/A Webwww.petiq.com Phone208-939-8900 Debt Debt-to-Equity Ratio0.56 Current Ratio2.00 Quick Ratio0.90 Price-To-Earnings Trailing P/E Ratio102.44 Forward P/E Ratio52.57 P/E Growth2.2 Sales & Book Value Annual Sales$266.69 million Price / Sales3.85 Cash Flow$0.3899 per share Price / Cash102.45 Book Value$4.88 per share Price / Book8.19 Profitability EPS (Most Recent Fiscal Year)$0.39 Net Income$-3,490,000.00 Net Margins-0.76% Return on Equity11.40% Return on Assets6.52% Miscellaneous Employees225 Outstanding Shares25,690,000Market Cap$1.07 billion PetIQ (NASDAQ:PETQ) Frequently Asked Questions What is PetIQ's stock symbol? PetIQ trades on the NASDAQ under the ticker symbol "PETQ." How were PetIQ's earnings last quarter? PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings results on Tuesday, August, 14th. The company reported $0.41 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.39 by $0.02. The firm had revenue of $171.10 million for the quarter, compared to the consensus estimate of $148.48 million. PetIQ had a negative net margin of 0.76% and a positive return on equity of 11.40%. The business's quarterly revenue was up 96.2% compared to the same quarter last year. View PetIQ's Earnings History. When is PetIQ's next earnings date? PetIQ is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for PetIQ. What price target have analysts set for PETQ? 3 brokers have issued 1-year target prices for PetIQ's shares. Their predictions range from $32.00 to $45.00. On average, they expect PetIQ's share price to reach $39.00 in the next year. This suggests that the stock has a possible downside of 2.4%. View Analyst Price Targets for PetIQ. What is the consensus analysts' recommendation for PetIQ? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ. What are Wall Street analysts saying about PetIQ stock? Here are some recent quotes from research analysts about PetIQ stock: 1. Jefferies Financial Group Inc analysts commented, "Median short interest for the Beverages group decreased -1.6% since 7/31, while positions against Household Products decreased -6.2% during the same period. Among the largest decreases in Beverages since 7/31 were KDP (-34%), PEP (-20%), and KO (-6%); among the largest decreases in HPC were KMB (-17%), CLX (-15%), and EPC (-14%). Median days to cover for Beverages are 2.3 and 6.7 for HPC. On the long side, we favor and MNST. Short interest update: Median short interest (SI) for the Beverages group decreased -1.6% since 7/31, while positions against the HPC group decreased -6.2%. In aggregate, short interest for the overall staples group decreased -2.5% since 7/31." (8/24/2018) 2. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (6/6/2018) Who are some of PetIQ's key competitors? Some companies that are related to PetIQ include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Aceto (ACET), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Medizone International (MZEI). Who are PetIQ's key executives? PetIQ's management team includes the folowing people: Mr. Mccord Christensen, Chairman of Directors & CEO (Age 46)Mr. John Newland, CFO & Corp. Sec. (Age 54) When did PetIQ IPO? (PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers. Has PetIQ been receiving favorable news coverage? News articles about PETQ stock have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PetIQ earned a daily sentiment score of 0.18 on Accern's scale. They also gave news articles about the company an impact score of 46.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for PetIQ. Who are PetIQ's major shareholders? PetIQ's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wasatch Advisors Inc. (7.93%), State of New Jersey Common Pension Fund D (3.83%), BlackRock Inc. (3.40%), Redwood Investments LLC (2.64%), Pembroke Management LTD (2.52%) and Massachusetts Financial Services Co. MA (2.35%). Company insiders that own PetIQ stock include John Newland, Mccord Christensen, Ronald Kennedy and Will Santana. View Institutional Ownership Trends for PetIQ. Which major investors are selling PetIQ stock? PETQ stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Fiera Capital Corp, Bank of New York Mellon Corp, Bank of New York Mellon Corp, Macquarie Group Ltd., Brown Advisory Inc., Bank of America Corp DE and Oppenheimer Asset Management Inc.. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mccord Christensen and Will Santana. View Insider Buying and Selling for PetIQ. Which major investors are buying PetIQ stock? PETQ stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., State of New Jersey Common Pension Fund D, Pembroke Management LTD, Massachusetts Financial Services Co. MA, Russell Investments Group Ltd., American Century Companies Inc., Fred Alger Management Inc. and Boston Partners. View Insider Buying and Selling for PetIQ. How do I buy shares of PetIQ? Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PetIQ's stock price today? One share of PETQ stock can currently be purchased for approximately $39.95. How big of a company is PetIQ? PetIQ has a market capitalization of $1.07 billion and generates $266.69 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. PetIQ employs 225 workers across the globe. How can I contact PetIQ? PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected] MarketBeat Community Rating for PetIQ (NASDAQ PETQ)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 176 (Vote Outperform)Underperform Votes: 172 (Vote Underperform)Total Votes: 348MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/20/2018 by MarketBeat.com StaffFeatured Article: Why is the ex-dividend date different from the record date?